|
| PRODUCT NAME: |
SESTRINE |
| • Active Ingredient |
Repaglinide 0,5 mg, 1mg and 2 mg. |
| • Description |
Oral hypoglycemic agent for the management of type 2 diabetes. |
| • Indication |
Reduces post-prandial increased glycemia in diabetics not satisfactorily controlled with diet and exercise. |
| • How Supplied |
0,5 mg: Blister containing 30 tablets. |
| 1 and 2 mg: Blister containing 30 and 90 tablets. |
|
